NCT05049681 2021-09-20
Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell
The First Affiliated Hospital of Zhengzhou University
Phase 3 Unknown
Clinical Trials
5 trialsNCT03671265 2019-01-09
Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown
NCT03285906 2017-09-18
An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Unknown
NCT02544737 2016-08-26
Apatinib for Metastatic Esophageal Cancer.
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT02683655 2016-02-17
Study of Apatinib in Metastatic Esophageal Cancer
Huai'an First People's Hospital
Phase 2 Unknown